PL3634384T3 - Roztwór lewodopy do infuzji - Google Patents
Roztwór lewodopy do infuzjiInfo
- Publication number
- PL3634384T3 PL3634384T3 PL18730319T PL18730319T PL3634384T3 PL 3634384 T3 PL3634384 T3 PL 3634384T3 PL 18730319 T PL18730319 T PL 18730319T PL 18730319 T PL18730319 T PL 18730319T PL 3634384 T3 PL3634384 T3 PL 3634384T3
- Authority
- PL
- Poland
- Prior art keywords
- infusion solution
- levodopa infusion
- levodopa
- solution
- infusion
- Prior art date
Links
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 title 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 title 1
- 239000003978 infusion fluid Substances 0.000 title 1
- 229960004502 levodopa Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1750707 | 2017-06-05 | ||
| PCT/EP2018/064774 WO2018224501A1 (en) | 2017-06-05 | 2018-06-05 | Levodopa infusion solution |
| EP18730319.3A EP3634384B1 (en) | 2017-06-05 | 2018-06-05 | Levodopa infusion solution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3634384T3 true PL3634384T3 (pl) | 2021-12-06 |
Family
ID=62567647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18730319T PL3634384T3 (pl) | 2017-06-05 | 2018-06-05 | Roztwór lewodopy do infuzji |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US11633353B2 (pl) |
| EP (2) | EP3838263A1 (pl) |
| JP (2) | JP7134228B2 (pl) |
| KR (1) | KR102437003B1 (pl) |
| CN (1) | CN110753538A (pl) |
| AR (1) | AR112070A1 (pl) |
| AU (1) | AU2018280745B2 (pl) |
| BR (1) | BR112019025215A2 (pl) |
| CA (1) | CA3065990A1 (pl) |
| CY (1) | CY1124236T1 (pl) |
| DK (1) | DK3634384T3 (pl) |
| EA (1) | EA201992685A1 (pl) |
| ES (1) | ES2866981T3 (pl) |
| HR (1) | HRP20210599T1 (pl) |
| HU (1) | HUE054268T2 (pl) |
| IL (1) | IL271169B (pl) |
| LT (1) | LT3634384T (pl) |
| MX (1) | MX2019014675A (pl) |
| PL (1) | PL3634384T3 (pl) |
| PT (1) | PT3634384T (pl) |
| RS (1) | RS61749B1 (pl) |
| SI (1) | SI3634384T1 (pl) |
| TW (1) | TW201902463A (pl) |
| WO (1) | WO2018224501A1 (pl) |
| ZA (1) | ZA201908027B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201992685A1 (ru) * | 2017-06-05 | 2020-06-05 | Дизлин Фармасьютикалз Аб | Раствор леводопы для инфузий |
| HUP2100456A1 (hu) * | 2021-12-28 | 2023-08-28 | Semmelweis Egyetem | Szemcsepp készítmény |
| EP4223288B1 (en) | 2022-02-07 | 2024-03-06 | Berlirem GmbH | Novel kit of pharmaceutical preparations for the treatment of parkinson's disease |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54105221A (en) | 1978-02-02 | 1979-08-18 | Sankyo Co Ltd | Preparation of stable concentrated dopa injection |
| SE512655C2 (sv) | 1993-11-17 | 2000-04-17 | Medmera Sweden Hb C O Nil Dizd | Infusionslösning för medicinskt bruk innehållande L-dopa |
| DE19757224A1 (de) | 1997-12-22 | 1999-07-01 | Bayer Ag | Verfahren und Vorrichtung zur in-situ-Formulierung einer Arzneistofflösung zur parenteralen Applikation |
| US8815950B2 (en) | 2003-08-29 | 2014-08-26 | Janssen Biotech, Inc. | Pharmaceutical compositions and method of using levodopa and carbidopa |
| ATE495739T1 (de) * | 2003-08-29 | 2011-02-15 | Transform Pharmaceuticals Inc | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa |
| CN1845728B (zh) | 2003-08-29 | 2013-06-19 | 转化医药公司 | 包含左旋多巴和卡比多巴的药物组合物 |
| SE0401842D0 (sv) * | 2004-07-12 | 2004-07-12 | Dizlin Medical Design Ab | Infusion and injection solution of levodopa |
| EP2432454B1 (en) | 2009-05-19 | 2017-03-01 | Neuroderm Ltd | Compositions for continuous administration of dopa decarboxylase inhibitors |
| DK3326615T3 (da) * | 2010-11-15 | 2020-03-09 | Neuroderm Ltd | Kontinuerlig indgivelse af l-dopa-, dopa- decarboxylase-inhibitorer, catechol-o-methyltransferaseinhibitorer og sammensætninger til samme |
| AU2011101361A4 (en) | 2010-11-15 | 2011-12-15 | Andrew Lumsden | A prefilled syringe for administering buffered lignocaine |
| CN102755252A (zh) | 2011-07-28 | 2012-10-31 | 辽宁海思科制药有限公司 | 一种新的包装氨基酸葡萄糖注射液的双室输液袋 |
| RU2677278C2 (ru) * | 2013-03-13 | 2019-01-16 | Неуродерм Лтд | Способ лечения болезни паркинсона |
| US10420888B2 (en) | 2013-09-03 | 2019-09-24 | Max Arocha | Double-chamber mixing syringe and method of use |
| EA201992685A1 (ru) * | 2017-06-05 | 2020-06-05 | Дизлин Фармасьютикалз Аб | Раствор леводопы для инфузий |
-
2018
- 2018-06-05 EA EA201992685A patent/EA201992685A1/ru unknown
- 2018-06-05 AR ARP180101500A patent/AR112070A1/es unknown
- 2018-06-05 IL IL271169A patent/IL271169B/en unknown
- 2018-06-05 TW TW107119351A patent/TW201902463A/zh unknown
- 2018-06-05 PT PT187303193T patent/PT3634384T/pt unknown
- 2018-06-05 AU AU2018280745A patent/AU2018280745B2/en active Active
- 2018-06-05 HU HUE18730319A patent/HUE054268T2/hu unknown
- 2018-06-05 KR KR1020197037906A patent/KR102437003B1/ko active IP Right Grant
- 2018-06-05 MX MX2019014675A patent/MX2019014675A/es unknown
- 2018-06-05 WO PCT/EP2018/064774 patent/WO2018224501A1/en active Search and Examination
- 2018-06-05 CN CN201880037143.6A patent/CN110753538A/zh active Pending
- 2018-06-05 RS RS20210467A patent/RS61749B1/sr unknown
- 2018-06-05 LT LTEP18730319.3T patent/LT3634384T/lt unknown
- 2018-06-05 EP EP21153018.3A patent/EP3838263A1/en active Pending
- 2018-06-05 BR BR112019025215-0A patent/BR112019025215A2/pt unknown
- 2018-06-05 CA CA3065990A patent/CA3065990A1/en active Pending
- 2018-06-05 PL PL18730319T patent/PL3634384T3/pl unknown
- 2018-06-05 ES ES18730319T patent/ES2866981T3/es active Active
- 2018-06-05 US US16/619,176 patent/US11633353B2/en active Active
- 2018-06-05 SI SI201830257T patent/SI3634384T1/sl unknown
- 2018-06-05 EP EP18730319.3A patent/EP3634384B1/en active Active
- 2018-06-05 DK DK18730319.3T patent/DK3634384T3/da active
- 2018-06-05 JP JP2020516960A patent/JP7134228B2/ja active Active
-
2019
- 2019-12-03 ZA ZA2019/08027A patent/ZA201908027B/en unknown
-
2021
- 2021-04-15 HR HRP20210599TT patent/HRP20210599T1/hr unknown
- 2021-04-23 CY CY20211100353T patent/CY1124236T1/el unknown
-
2022
- 2022-06-29 JP JP2022104764A patent/JP7437450B2/ja active Active
-
2023
- 2023-02-28 US US18/175,599 patent/US20230330015A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268071A (en) | blood pump | |
| IL273154A (en) | blood pump | |
| HK1232115A1 (zh) | 咬合夾板裝置 | |
| GB201503472D0 (en) | Urostomy appliance | |
| IL253836A0 (en) | ostomy device | |
| SG11201706448YA (en) | Infusion set | |
| IL271169A (en) | An infusion of levodopa | |
| ZA201805549B (en) | Syringe | |
| SG11201801890WA (en) | Infusion set | |
| GB2568283B (en) | Pumps | |
| EP3666312C0 (en) | INTERMITTENT INFUSION | |
| GB201507157D0 (en) | Ambulatory devices | |
| PL3729605T3 (pl) | Pompa z wirnikiem mokrym | |
| GB2577818B (en) | Pumps | |
| GB201717433D0 (en) | Infusion systems | |
| GB2580810B (en) | Pumps | |
| GB201705458D0 (en) | Infusion pump | |
| GB201718608D0 (en) | Improved pump | |
| GB201715510D0 (en) | Infusion device | |
| GB201712992D0 (en) | New medical uses | |
| GB201717593D0 (en) | Novel microneedle | |
| GB201704107D0 (en) | New medical uses | |
| GB201704846D0 (en) | Pump | |
| ZA201702038B (en) | Pump arrangement | |
| GB2544782B (en) | Solution |